CoChat

Mutational Analysis of Tyr-501 of HIV-1 Reverse Transcriptase

Open access
Arion, Dominique, Sluis-Cremer, Nicolas, Min, Kyung-Lyum, Abram, Michael E., Fletcher, Ronald S., Parniak, Michael A. · 2002 · Journal of Biological Chemistry
Cited by 50

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

N-(4-tert-Butylbenzoyl)-2-hydroxynaphthaldehyde hydrazone (BBNH) is a potent inhibitor of the ribonuclease H (RNase H) activity of human immunodeficiency virus (HIV)-1 reverse transcriptase (RT). Molecular modeling predicted that BBNH binds to the HIV-1 RT RNase H active site via two major interactions, coordination to the metal ion cofactor (Mg(2+) or Mn(2+)) in the enzyme active site and aromatic ring-stacking interaction between the naphthyl ring of BBNH and amino acid Tyr-501. The latter residue equivalent is conserved in virtually all RNases H, suggesting the need for an aromatic or pi-stacking interaction in this region. To assess the importance of Tyr-501 in the binding of BBNH for the inhibition of RT RNase H activity, we used site-specific mutagenesis to generate RT with a variety of substitutions at this position. Most substitutions resulted virtually in a complete loss of RNase H activity. However, three mutants, Y501F, Y501W, and Y501R, possessed RNase H activities comparable with wild-type enzyme. Whereas BBNH inhibited Y501F RT RNase H activity with potency equivalent to wild-type RT, the Y501W mutant showed a 6-fold resistance to inhibition by BBNH, and the Y501R mutant was completely resistant to inhibition by BBNH. The replication "fitness" of HIV molecular clones with the Y501W or Y510R mutation was significantly compromised compared with wild-type virus. Importantly, BBNH was an effective inhibitor of the DNA polymerase activity of all Y501X mutants tested. Our results highlight the importance of Tyr-501 in RT RNase H activity and in N-acylhydrazone inhibitor binding and suggest that drugs that target critical residues in HIV-1 proteins may be a useful approach in new antiviral development.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m110254200

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 21

  1. Parniak, 2000, Adv. Pharmacol., 49, 67, 10.1016/S1054-3589(00)49024-1 · DOI
  2. Loya, 1990, Antimicrob. Agents Chemother., 34, 2009, 10.1128/AAC.34.10.2009 · DOI
  3. Tan, 1991, Biochemistry, 30, 4831, 10.1021/bi00234a001 · doi:10.1021/bi00234a001
  4. Zhan, 1994, Biochemistry, 33, 1366, 10.1021/bi00172a012 · DOI
  5. Mohan, 1994, J. Med. Chem., 37, 2513, 10.1021/jm00042a004 · DOI
  6. Loya, 1997, J. Virol., 71, 5668, 10.1128/JVI.71.7.5668-5672.1997 · DOI
  7. Buckheit, 1999, Antiviral Chem. Chemother., 1, 23, 10.1177/095632029901000103 · DOI
  8. Hnatyszyn, 1999, Phytother. Res., 13, 206, 10.1002/(SICI)1099-1573(199905)13:3<206::AID-PTR409>3.0.CO;2-D · doi:10.1002/(sici)1099-1573(199905)13:3<206::aid-ptr409>3.0.co;2-d
  9. Min, 2000, Chem. Pharm. Bull. (Tokyo), 48, 194, 10.1248/cpb.48.194 · doi:10.1248/cpb.48.194
  10. Borkow, 1997, Biochemistry, 36, 3179, 10.1021/bi9624696 · DOI · Paper page
  11. Gabbara, 1999, Biochemistry, 38, 13070, 10.1021/bi991085n · doi:10.1021/bi991085n
  12. Baker, 1992, Hepatology, 15, 492, 10.1002/hep.1840150323 · DOI · Paper page
  13. Edward, 1988, J. Chem. Eng. Data, 33, 538, 10.1021/je00054a044 · DOI · Paper page
  14. Lanthier, 1997, Bioorg. Med. Chem. Lett., 7, 1557, 10.1016/S0960-894X(97)00267-9 · DOI
  15. Fletcher, 1996, Protein Expression Purif., 7, 27, 10.1006/prep.1996.0004 · DOI
  16. Arts, 1994, J. Biol. Chem., 269, 14672, 10.1016/S0021-9258(17)36678-4 · DOI · Paper page
  17. Fisher, 1991, Nature, 316, 262, 10.1038/316262a0 · DOI · Paper page
  18. Gopalakrishnan, 1994, J. Biol. Chem., 269, 4110, 10.1016/S0021-9258(17)41750-9 · DOI
  19. Mizuguchi, 1998, Protein Sci., 7, 2469, 10.1002/pro.5560071126 · DOI · Paper page
  20. Ding, 1998, J. Mol. Biol., 284, 1095, 10.1006/jmbi.1998.2208 · DOI · Paper page
  21. Huang, 1998, Science, 282, 1669, 10.1126/science.282.5394.1669 · DOI · Paper page

Cited by

See all 50

Metadata

Authors
Arion, D., Sluis-Cremer, N., Min, K.-L., Abram, M. E., Fletcher, R. S., & Parniak, M. A.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2002-01
Volume
277
Issue
2
Pages
1370-1374
ISSN
0021-9258 (ISSN-L)
OpenAlex
W2078861644
Cited by
50
References
2
FWCI
2.40
Type
journal article
Language
en
Open access
hybrid
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mutational Analysis of Tyr-501 of HIV-1 Reverse Transcriptase. https://app.cochat.ai/papers/10.1074/jbc.m110254200
The paper
Arion, D., Sluis-Cremer, N., Min, K.-L., Abram, M. E., Fletcher, R. S., & Parniak, M. A. (2002). Mutational Analysis of Tyr-501 of HIV-1 Reverse Transcriptase. Journal of Biological Chemistry. https://doi.org/10.1074/jbc.m110254200

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.